Abstract
Advancements in cancer treatment and survivorship rely on participation in research and access to health records. This study explored preferences for data access and sharing in 14 workshops with 42 community members, most of whom were a cancer survivor or carer. Various scenarios for data access and sharing were presented and discussed, with participants’ preferences summarized using descriptive statistics. Reasons underlying these preferences were identified through a thematic analysis of workshop transcripts. Most participants indicated a willingness for researchers to use their self-reported data and current health records for a specific research project (86%). Many were also willing for their self-reported data and current (62%) or all future (44%) heath records to be shared with other researchers for use in other studies if made aware of this. Willingness to consent to data access and sharing data in cancer research was influenced by: (i) the potential for data sharing to advance medical discoveries and benefit people impacted by cancer in the future, (ii) transparency around researchers’ credibility and their intentions for data sharing, (iii) level of ownership and control over data sharing, and (iv) protocols for privacy and confidentiality in data sharing. Based on these themes, we present practical strategies for optimizing data access and sharing in cancer research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by Cancer Council Queensland.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Southern Queensland Human Research Ethics Committee gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email Addresses: Elizabeth: e23.johnston{at}qut.edu.au, Xanthia: xanthiabourdaniotis{at}cancerqld.org.au, Susannah: susannahayre{at}cancerqld.org.au, Leah: leahzajdlewicz{at}cancerqld.org.au, Vanessa: Vanessa.Beesley{at}qimrberghofer.edu.au, Belinda: belindagoodwin{at}cancerqld.org.au
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
